nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—Lisinopril—coronary artery disease	0.536	1	CrCtD
Lisdexamfetamine—Lisinopril—Enalapril—coronary artery disease	0.0598	0.18	CrCrCtD
Lisdexamfetamine—Lisinopril—Trandolapril—coronary artery disease	0.0598	0.18	CrCrCtD
Lisdexamfetamine—Aspartame—Enalapril—coronary artery disease	0.0475	0.143	CrCrCtD
Lisdexamfetamine—Aspartame—Trandolapril—coronary artery disease	0.0475	0.143	CrCrCtD
Lisdexamfetamine—Lisinopril—Ramipril—coronary artery disease	0.0453	0.136	CrCrCtD
Lisdexamfetamine—Aspartame—Lisinopril—coronary artery disease	0.0372	0.112	CrCrCtD
Lisdexamfetamine—Aspartame—Ramipril—coronary artery disease	0.036	0.108	CrCrCtD
Lisdexamfetamine—Lisinopril—ACE2—coronary artery disease	0.00089	0.407	CrCbGaD
Lisdexamfetamine—Lacosamide—CA5B—coronary artery disease	0.000374	0.171	CrCbGaD
Lisdexamfetamine—Lisinopril—ACE—coronary artery disease	0.000188	0.086	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC22A3—coronary artery disease	0.000164	0.0751	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC22A3—coronary artery disease	0.000152	0.0696	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB1—coronary artery disease	0.000148	0.0676	CrCbGaD
Lisdexamfetamine—Labetalol—ADRB2—coronary artery disease	0.000124	0.0568	CrCbGaD
Lisdexamfetamine—Selegiline—CYP2C19—coronary artery disease	7.78e-05	0.0356	CrCbGaD
Lisdexamfetamine—Decreased appetite—Perindopril—coronary artery disease	7.28e-05	0.000747	CcSEcCtD
Lisdexamfetamine—Dizziness—Lovastatin—coronary artery disease	7.28e-05	0.000746	CcSEcCtD
Lisdexamfetamine—Nervousness—Lisinopril—coronary artery disease	7.27e-05	0.000746	CcSEcCtD
Lisdexamfetamine—Somnolence—Furosemide—coronary artery disease	7.24e-05	0.000743	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Perindopril—coronary artery disease	7.23e-05	0.000742	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Eplerenone—coronary artery disease	7.23e-05	0.000741	CcSEcCtD
Lisdexamfetamine—Fatigue—Perindopril—coronary artery disease	7.22e-05	0.000741	CcSEcCtD
Lisdexamfetamine—Urticaria—Trandolapril—coronary artery disease	7.18e-05	0.000736	CcSEcCtD
Lisdexamfetamine—Constipation—Perindopril—coronary artery disease	7.17e-05	0.000735	CcSEcCtD
Lisdexamfetamine—Vomiting—Fenofibrate—coronary artery disease	7.16e-05	0.000735	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Valsartan—coronary artery disease	7.16e-05	0.000734	CcSEcCtD
Lisdexamfetamine—Convulsion—Ramipril—coronary artery disease	7.16e-05	0.000734	CcSEcCtD
Lisdexamfetamine—Urticaria—Enalapril—coronary artery disease	7.15e-05	0.000733	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Trandolapril—coronary artery disease	7.14e-05	0.000733	CcSEcCtD
Lisdexamfetamine—Dizziness—Ezetimibe—coronary artery disease	7.14e-05	0.000732	CcSEcCtD
Lisdexamfetamine—Palpitations—Timolol—coronary artery disease	7.13e-05	0.000732	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Enalapril—coronary artery disease	7.11e-05	0.00073	CcSEcCtD
Lisdexamfetamine—Insomnia—Losartan—coronary artery disease	7.11e-05	0.000729	CcSEcCtD
Lisdexamfetamine—Rash—Fenofibrate—coronary artery disease	7.1e-05	0.000729	CcSEcCtD
Lisdexamfetamine—Dermatitis—Fenofibrate—coronary artery disease	7.1e-05	0.000728	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Furosemide—coronary artery disease	7.08e-05	0.000726	CcSEcCtD
Lisdexamfetamine—Headache—Fenofibrate—coronary artery disease	7.06e-05	0.000724	CcSEcCtD
Lisdexamfetamine—Vision blurred—Lisinopril—coronary artery disease	7.06e-05	0.000724	CcSEcCtD
Lisdexamfetamine—Urticaria—Telmisartan—coronary artery disease	7.05e-05	0.000723	CcSEcCtD
Lisdexamfetamine—Vomiting—Clopidogrel—coronary artery disease	7.04e-05	0.000722	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Simvastatin—coronary artery disease	7.04e-05	0.000722	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Furosemide—coronary artery disease	7.03e-05	0.000721	CcSEcCtD
Lisdexamfetamine—Fatigue—Furosemide—coronary artery disease	7.02e-05	0.00072	CcSEcCtD
Lisdexamfetamine—Tremor—Lisinopril—coronary artery disease	7.02e-05	0.00072	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Telmisartan—coronary artery disease	7.02e-05	0.00072	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Losartan—coronary artery disease	7.01e-05	0.000719	CcSEcCtD
Lisdexamfetamine—Anxiety—Ramipril—coronary artery disease	7.01e-05	0.000719	CcSEcCtD
Lisdexamfetamine—Vomiting—Lovastatin—coronary artery disease	7e-05	0.000718	CcSEcCtD
Lisdexamfetamine—Somnolence—Losartan—coronary artery disease	6.99e-05	0.000717	CcSEcCtD
Lisdexamfetamine—Dizziness—Eplerenone—coronary artery disease	6.98e-05	0.000716	CcSEcCtD
Lisdexamfetamine—Rash—Clopidogrel—coronary artery disease	6.98e-05	0.000716	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.98e-05	0.000716	CcSEcCtD
Lisdexamfetamine—Dermatitis—Clopidogrel—coronary artery disease	6.98e-05	0.000716	CcSEcCtD
Lisdexamfetamine—Asthenia—Valsartan—coronary artery disease	6.97e-05	0.000715	CcSEcCtD
Lisdexamfetamine—Hypertension—Timolol—coronary artery disease	6.97e-05	0.000715	CcSEcCtD
Lisdexamfetamine—Constipation—Furosemide—coronary artery disease	6.97e-05	0.000715	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Niacin—coronary artery disease	6.96e-05	0.000714	CcSEcCtD
Lisdexamfetamine—Asthenia—Olmesartan—coronary artery disease	6.94e-05	0.000712	CcSEcCtD
Lisdexamfetamine—Headache—Clopidogrel—coronary artery disease	6.94e-05	0.000712	CcSEcCtD
Lisdexamfetamine—Rash—Lovastatin—coronary artery disease	6.94e-05	0.000712	CcSEcCtD
Lisdexamfetamine—Dermatitis—Lovastatin—coronary artery disease	6.93e-05	0.000711	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Losartan—coronary artery disease	6.92e-05	0.00071	CcSEcCtD
Lisdexamfetamine—Headache—Lovastatin—coronary artery disease	6.89e-05	0.000707	CcSEcCtD
Lisdexamfetamine—Dry mouth—Ramipril—coronary artery disease	6.88e-05	0.000705	CcSEcCtD
Lisdexamfetamine—Vomiting—Ezetimibe—coronary artery disease	6.86e-05	0.000704	CcSEcCtD
Lisdexamfetamine—Phenelzine—CYP2C19—coronary artery disease	6.86e-05	0.0314	CrCbGaD
Lisdexamfetamine—Hypersensitivity—Pravastatin—coronary artery disease	6.86e-05	0.000703	CcSEcCtD
Lisdexamfetamine—Anxiety—Timolol—coronary artery disease	6.85e-05	0.000703	CcSEcCtD
Lisdexamfetamine—Angioedema—Lisinopril—coronary artery disease	6.84e-05	0.000702	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Losartan—coronary artery disease	6.83e-05	0.000701	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.83e-05	0.0007	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Captopril—coronary artery disease	6.82e-05	0.0007	CcSEcCtD
Lisdexamfetamine—Dizziness—Simvastatin—coronary artery disease	6.81e-05	0.000698	CcSEcCtD
Lisdexamfetamine—Rash—Ezetimibe—coronary artery disease	6.8e-05	0.000698	CcSEcCtD
Lisdexamfetamine—Dermatitis—Ezetimibe—coronary artery disease	6.8e-05	0.000697	CcSEcCtD
Lisdexamfetamine—Asthenia—Niacin—coronary artery disease	6.78e-05	0.000695	CcSEcCtD
Lisdexamfetamine—Fatigue—Losartan—coronary artery disease	6.78e-05	0.000695	CcSEcCtD
Lisdexamfetamine—Headache—Ezetimibe—coronary artery disease	6.76e-05	0.000693	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Ramipril—coronary artery disease	6.74e-05	0.000691	CcSEcCtD
Lisdexamfetamine—Dry mouth—Timolol—coronary artery disease	6.72e-05	0.000689	CcSEcCtD
Lisdexamfetamine—Constipation—Losartan—coronary artery disease	6.72e-05	0.000689	CcSEcCtD
Lisdexamfetamine—Vomiting—Eplerenone—coronary artery disease	6.72e-05	0.000689	CcSEcCtD
Lisdexamfetamine—Nausea—Fenofibrate—coronary artery disease	6.69e-05	0.000686	CcSEcCtD
Lisdexamfetamine—Asthenia—Pravastatin—coronary artery disease	6.68e-05	0.000685	CcSEcCtD
Lisdexamfetamine—Rash—Eplerenone—coronary artery disease	6.66e-05	0.000683	CcSEcCtD
Lisdexamfetamine—Urticaria—Perindopril—coronary artery disease	6.66e-05	0.000683	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Trandolapril—coronary artery disease	6.66e-05	0.000683	CcSEcCtD
Lisdexamfetamine—Dermatitis—Eplerenone—coronary artery disease	6.65e-05	0.000682	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Valsartan—coronary artery disease	6.65e-05	0.000682	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Enalapril—coronary artery disease	6.63e-05	0.00068	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Perindopril—coronary artery disease	6.62e-05	0.000679	CcSEcCtD
Lisdexamfetamine—Palpitations—Lisinopril—coronary artery disease	6.62e-05	0.000679	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Olmesartan—coronary artery disease	6.62e-05	0.000679	CcSEcCtD
Lisdexamfetamine—Headache—Eplerenone—coronary artery disease	6.62e-05	0.000679	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Ramipril—coronary artery disease	6.61e-05	0.000678	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Timolol—coronary artery disease	6.59e-05	0.000676	CcSEcCtD
Lisdexamfetamine—Nausea—Clopidogrel—coronary artery disease	6.58e-05	0.000675	CcSEcCtD
Lisdexamfetamine—Tachycardia—Ramipril—coronary artery disease	6.58e-05	0.000675	CcSEcCtD
Lisdexamfetamine—Skin disorder—Ramipril—coronary artery disease	6.55e-05	0.000671	CcSEcCtD
Lisdexamfetamine—Vomiting—Simvastatin—coronary artery disease	6.54e-05	0.000671	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Telmisartan—coronary artery disease	6.54e-05	0.000671	CcSEcCtD
Lisdexamfetamine—Nausea—Lovastatin—coronary artery disease	6.54e-05	0.00067	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Ramipril—coronary artery disease	6.52e-05	0.000668	CcSEcCtD
Lisdexamfetamine—Rash—Simvastatin—coronary artery disease	6.49e-05	0.000666	CcSEcCtD
Lisdexamfetamine—Dermatitis—Simvastatin—coronary artery disease	6.48e-05	0.000665	CcSEcCtD
Lisdexamfetamine—Asthenia—Trandolapril—coronary artery disease	6.48e-05	0.000665	CcSEcCtD
Lisdexamfetamine—Urticaria—Furosemide—coronary artery disease	6.47e-05	0.000664	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Niacin—coronary artery disease	6.47e-05	0.000663	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Timolol—coronary artery disease	6.46e-05	0.000663	CcSEcCtD
Lisdexamfetamine—Asthenia—Enalapril—coronary artery disease	6.46e-05	0.000662	CcSEcCtD
Lisdexamfetamine—Headache—Simvastatin—coronary artery disease	6.45e-05	0.000661	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Furosemide—coronary artery disease	6.44e-05	0.000661	CcSEcCtD
Lisdexamfetamine—Dizziness—Valsartan—coronary artery disease	6.43e-05	0.000659	CcSEcCtD
Lisdexamfetamine—Anorexia—Ramipril—coronary artery disease	6.42e-05	0.000659	CcSEcCtD
Lisdexamfetamine—Nausea—Ezetimibe—coronary artery disease	6.41e-05	0.000657	CcSEcCtD
Lisdexamfetamine—Skin disorder—Timolol—coronary artery disease	6.4e-05	0.000656	CcSEcCtD
Lisdexamfetamine—Dizziness—Olmesartan—coronary artery disease	6.4e-05	0.000656	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Timolol—coronary artery disease	6.37e-05	0.000653	CcSEcCtD
Lisdexamfetamine—Asthenia—Telmisartan—coronary artery disease	6.37e-05	0.000653	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Pravastatin—coronary artery disease	6.37e-05	0.000653	CcSEcCtD
Lisdexamfetamine—Anxiety—Lisinopril—coronary artery disease	6.35e-05	0.000652	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.33e-05	0.000649	CcSEcCtD
Lisdexamfetamine—Anorexia—Timolol—coronary artery disease	6.28e-05	0.000644	CcSEcCtD
Lisdexamfetamine—Nausea—Eplerenone—coronary artery disease	6.27e-05	0.000643	CcSEcCtD
Lisdexamfetamine—Dizziness—Niacin—coronary artery disease	6.25e-05	0.000641	CcSEcCtD
Lisdexamfetamine—Urticaria—Losartan—coronary artery disease	6.24e-05	0.00064	CcSEcCtD
Lisdexamfetamine—Dry mouth—Lisinopril—coronary artery disease	6.24e-05	0.00064	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Losartan—coronary artery disease	6.21e-05	0.000637	CcSEcCtD
Lisdexamfetamine—Asthenia—Captopril—coronary artery disease	6.19e-05	0.000635	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Trandolapril—coronary artery disease	6.18e-05	0.000634	CcSEcCtD
Lisdexamfetamine—Vomiting—Valsartan—coronary artery disease	6.18e-05	0.000634	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Enalapril—coronary artery disease	6.16e-05	0.000632	CcSEcCtD
Lisdexamfetamine—Dizziness—Pravastatin—coronary artery disease	6.15e-05	0.000631	CcSEcCtD
Lisdexamfetamine—Vomiting—Olmesartan—coronary artery disease	6.15e-05	0.000631	CcSEcCtD
Lisdexamfetamine—Rash—Valsartan—coronary artery disease	6.13e-05	0.000629	CcSEcCtD
Lisdexamfetamine—Dermatitis—Valsartan—coronary artery disease	6.12e-05	0.000628	CcSEcCtD
Lisdexamfetamine—Nausea—Simvastatin—coronary artery disease	6.11e-05	0.000627	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Lisinopril—coronary artery disease	6.11e-05	0.000627	CcSEcCtD
Lisdexamfetamine—Rash—Olmesartan—coronary artery disease	6.1e-05	0.000625	CcSEcCtD
Lisdexamfetamine—Insomnia—Ramipril—coronary artery disease	6.1e-05	0.000625	CcSEcCtD
Lisdexamfetamine—Dermatitis—Olmesartan—coronary artery disease	6.09e-05	0.000625	CcSEcCtD
Lisdexamfetamine—Headache—Valsartan—coronary artery disease	6.09e-05	0.000624	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Telmisartan—coronary artery disease	6.07e-05	0.000623	CcSEcCtD
Lisdexamfetamine—Headache—Olmesartan—coronary artery disease	6.06e-05	0.000621	CcSEcCtD
Lisdexamfetamine—Asthenia—Perindopril—coronary artery disease	6.01e-05	0.000617	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Ramipril—coronary artery disease	6.01e-05	0.000616	CcSEcCtD
Lisdexamfetamine—Vomiting—Niacin—coronary artery disease	6.01e-05	0.000616	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Furosemide—coronary artery disease	6e-05	0.000616	CcSEcCtD
Lisdexamfetamine—Somnolence—Ramipril—coronary artery disease	5.99e-05	0.000615	CcSEcCtD
Lisdexamfetamine—Dizziness—Trandolapril—coronary artery disease	5.97e-05	0.000613	CcSEcCtD
Lisdexamfetamine—Tachycardia—Lisinopril—coronary artery disease	5.97e-05	0.000612	CcSEcCtD
Lisdexamfetamine—Insomnia—Timolol—coronary artery disease	5.96e-05	0.000611	CcSEcCtD
Lisdexamfetamine—Rash—Niacin—coronary artery disease	5.96e-05	0.000611	CcSEcCtD
Lisdexamfetamine—Dermatitis—Niacin—coronary artery disease	5.95e-05	0.000611	CcSEcCtD
Lisdexamfetamine—Dizziness—Enalapril—coronary artery disease	5.95e-05	0.00061	CcSEcCtD
Lisdexamfetamine—Skin disorder—Lisinopril—coronary artery disease	5.94e-05	0.000609	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Ramipril—coronary artery disease	5.93e-05	0.000609	CcSEcCtD
Lisdexamfetamine—Headache—Niacin—coronary artery disease	5.92e-05	0.000607	CcSEcCtD
Lisdexamfetamine—Vomiting—Pravastatin—coronary artery disease	5.92e-05	0.000607	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Lisinopril—coronary artery disease	5.91e-05	0.000606	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Captopril—coronary artery disease	5.91e-05	0.000606	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Timolol—coronary artery disease	5.87e-05	0.000602	CcSEcCtD
Lisdexamfetamine—Dizziness—Telmisartan—coronary artery disease	5.87e-05	0.000602	CcSEcCtD
Lisdexamfetamine—Rash—Pravastatin—coronary artery disease	5.87e-05	0.000602	CcSEcCtD
Lisdexamfetamine—Dermatitis—Pravastatin—coronary artery disease	5.86e-05	0.000601	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Ramipril—coronary artery disease	5.86e-05	0.000601	CcSEcCtD
Lisdexamfetamine—Somnolence—Timolol—coronary artery disease	5.86e-05	0.000601	CcSEcCtD
Lisdexamfetamine—Asthenia—Furosemide—coronary artery disease	5.84e-05	0.000599	CcSEcCtD
Lisdexamfetamine—Headache—Pravastatin—coronary artery disease	5.83e-05	0.000598	CcSEcCtD
Lisdexamfetamine—Anorexia—Lisinopril—coronary artery disease	5.83e-05	0.000598	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Ramipril—coronary artery disease	5.82e-05	0.000597	CcSEcCtD
Lisdexamfetamine—Fatigue—Ramipril—coronary artery disease	5.81e-05	0.000596	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Timolol—coronary artery disease	5.8e-05	0.000595	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Losartan—coronary artery disease	5.79e-05	0.000594	CcSEcCtD
Lisdexamfetamine—Nausea—Valsartan—coronary artery disease	5.77e-05	0.000592	CcSEcCtD
Lisdexamfetamine—Constipation—Ramipril—coronary artery disease	5.76e-05	0.000591	CcSEcCtD
Lisdexamfetamine—Nausea—Olmesartan—coronary artery disease	5.75e-05	0.000589	CcSEcCtD
Lisdexamfetamine—Vomiting—Trandolapril—coronary artery disease	5.74e-05	0.000589	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Perindopril—coronary artery disease	5.73e-05	0.000588	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Timolol—coronary artery disease	5.73e-05	0.000587	CcSEcCtD
Lisdexamfetamine—Vomiting—Enalapril—coronary artery disease	5.72e-05	0.000587	CcSEcCtD
Lisdexamfetamine—Dizziness—Captopril—coronary artery disease	5.71e-05	0.000585	CcSEcCtD
Lisdexamfetamine—Rash—Trandolapril—coronary artery disease	5.7e-05	0.000584	CcSEcCtD
Lisdexamfetamine—Dermatitis—Trandolapril—coronary artery disease	5.69e-05	0.000584	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Timolol—coronary artery disease	5.69e-05	0.000583	CcSEcCtD
Lisdexamfetamine—Fatigue—Timolol—coronary artery disease	5.68e-05	0.000583	CcSEcCtD
Lisdexamfetamine—Rash—Enalapril—coronary artery disease	5.67e-05	0.000582	CcSEcCtD
Lisdexamfetamine—Dermatitis—Enalapril—coronary artery disease	5.67e-05	0.000581	CcSEcCtD
Lisdexamfetamine—Headache—Trandolapril—coronary artery disease	5.66e-05	0.000581	CcSEcCtD
Lisdexamfetamine—Vomiting—Telmisartan—coronary artery disease	5.64e-05	0.000579	CcSEcCtD
Lisdexamfetamine—Asthenia—Losartan—coronary artery disease	5.64e-05	0.000578	CcSEcCtD
Lisdexamfetamine—Headache—Enalapril—coronary artery disease	5.64e-05	0.000578	CcSEcCtD
Lisdexamfetamine—Nausea—Niacin—coronary artery disease	5.61e-05	0.000576	CcSEcCtD
Lisdexamfetamine—Rash—Telmisartan—coronary artery disease	5.6e-05	0.000574	CcSEcCtD
Lisdexamfetamine—Dermatitis—Telmisartan—coronary artery disease	5.59e-05	0.000573	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Furosemide—coronary artery disease	5.57e-05	0.000572	CcSEcCtD
Lisdexamfetamine—Headache—Telmisartan—coronary artery disease	5.56e-05	0.00057	CcSEcCtD
Lisdexamfetamine—Dizziness—Perindopril—coronary artery disease	5.54e-05	0.000568	CcSEcCtD
Lisdexamfetamine—Insomnia—Lisinopril—coronary artery disease	5.53e-05	0.000567	CcSEcCtD
Lisdexamfetamine—Nausea—Pravastatin—coronary artery disease	5.53e-05	0.000567	CcSEcCtD
Lisdexamfetamine—Vomiting—Captopril—coronary artery disease	5.49e-05	0.000563	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Lisinopril—coronary artery disease	5.45e-05	0.000559	CcSEcCtD
Lisdexamfetamine—Rash—Captopril—coronary artery disease	5.44e-05	0.000558	CcSEcCtD
Lisdexamfetamine—Dermatitis—Captopril—coronary artery disease	5.44e-05	0.000558	CcSEcCtD
Lisdexamfetamine—Somnolence—Lisinopril—coronary artery disease	5.43e-05	0.000557	CcSEcCtD
Lisdexamfetamine—Headache—Captopril—coronary artery disease	5.41e-05	0.000555	CcSEcCtD
Lisdexamfetamine—Dizziness—Furosemide—coronary artery disease	5.39e-05	0.000553	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Lisinopril—coronary artery disease	5.38e-05	0.000552	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Losartan—coronary artery disease	5.38e-05	0.000552	CcSEcCtD
Lisdexamfetamine—Nausea—Trandolapril—coronary artery disease	5.37e-05	0.00055	CcSEcCtD
Lisdexamfetamine—Urticaria—Ramipril—coronary artery disease	5.35e-05	0.000549	CcSEcCtD
Lisdexamfetamine—Nausea—Enalapril—coronary artery disease	5.35e-05	0.000548	CcSEcCtD
Lisdexamfetamine—Vomiting—Perindopril—coronary artery disease	5.33e-05	0.000546	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Ramipril—coronary artery disease	5.33e-05	0.000546	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Lisinopril—coronary artery disease	5.31e-05	0.000545	CcSEcCtD
Lisdexamfetamine—Rash—Perindopril—coronary artery disease	5.28e-05	0.000542	CcSEcCtD
Lisdexamfetamine—Dermatitis—Perindopril—coronary artery disease	5.28e-05	0.000541	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.28e-05	0.000541	CcSEcCtD
Lisdexamfetamine—Nausea—Telmisartan—coronary artery disease	5.27e-05	0.000541	CcSEcCtD
Lisdexamfetamine—Fatigue—Lisinopril—coronary artery disease	5.27e-05	0.000541	CcSEcCtD
Lisdexamfetamine—Headache—Perindopril—coronary artery disease	5.25e-05	0.000538	CcSEcCtD
Lisdexamfetamine—Urticaria—Timolol—coronary artery disease	5.23e-05	0.000537	CcSEcCtD
Lisdexamfetamine—Constipation—Lisinopril—coronary artery disease	5.23e-05	0.000536	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Timolol—coronary artery disease	5.21e-05	0.000534	CcSEcCtD
Lisdexamfetamine—Dizziness—Losartan—coronary artery disease	5.2e-05	0.000533	CcSEcCtD
Lisdexamfetamine—Vomiting—Furosemide—coronary artery disease	5.18e-05	0.000531	CcSEcCtD
Lisdexamfetamine—Rash—Furosemide—coronary artery disease	5.14e-05	0.000527	CcSEcCtD
Lisdexamfetamine—Dermatitis—Furosemide—coronary artery disease	5.13e-05	0.000526	CcSEcCtD
Lisdexamfetamine—Nausea—Captopril—coronary artery disease	5.13e-05	0.000526	CcSEcCtD
Lisdexamfetamine—Headache—Furosemide—coronary artery disease	5.1e-05	0.000523	CcSEcCtD
Lisdexamfetamine—Vomiting—Losartan—coronary artery disease	5e-05	0.000513	CcSEcCtD
Lisdexamfetamine—Nausea—Perindopril—coronary artery disease	4.98e-05	0.000511	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Ramipril—coronary artery disease	4.97e-05	0.000509	CcSEcCtD
Lisdexamfetamine—Rash—Losartan—coronary artery disease	4.96e-05	0.000508	CcSEcCtD
Lisdexamfetamine—Dermatitis—Losartan—coronary artery disease	4.95e-05	0.000508	CcSEcCtD
Lisdexamfetamine—Headache—Losartan—coronary artery disease	4.92e-05	0.000505	CcSEcCtD
Lisdexamfetamine—Urticaria—Lisinopril—coronary artery disease	4.86e-05	0.000498	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Timolol—coronary artery disease	4.85e-05	0.000498	CcSEcCtD
Lisdexamfetamine—Nausea—Furosemide—coronary artery disease	4.84e-05	0.000496	CcSEcCtD
Lisdexamfetamine—Asthenia—Ramipril—coronary artery disease	4.84e-05	0.000496	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Lisinopril—coronary artery disease	4.83e-05	0.000496	CcSEcCtD
Lisdexamfetamine—Asthenia—Timolol—coronary artery disease	4.73e-05	0.000485	CcSEcCtD
Lisdexamfetamine—Nausea—Losartan—coronary artery disease	4.67e-05	0.000479	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Ramipril—coronary artery disease	4.61e-05	0.000473	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Timolol—coronary artery disease	4.51e-05	0.000462	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Lisinopril—coronary artery disease	4.5e-05	0.000462	CcSEcCtD
Lisdexamfetamine—Dizziness—Ramipril—coronary artery disease	4.46e-05	0.000457	CcSEcCtD
Lisdexamfetamine—Asthenia—Lisinopril—coronary artery disease	4.39e-05	0.00045	CcSEcCtD
Lisdexamfetamine—Dizziness—Timolol—coronary artery disease	4.36e-05	0.000447	CcSEcCtD
Lisdexamfetamine—Vomiting—Ramipril—coronary artery disease	4.29e-05	0.00044	CcSEcCtD
Lisdexamfetamine—Rash—Ramipril—coronary artery disease	4.25e-05	0.000436	CcSEcCtD
Lisdexamfetamine—Dermatitis—Ramipril—coronary artery disease	4.25e-05	0.000435	CcSEcCtD
Lisdexamfetamine—Headache—Ramipril—coronary artery disease	4.22e-05	0.000433	CcSEcCtD
Lisdexamfetamine—Vomiting—Timolol—coronary artery disease	4.19e-05	0.00043	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Lisinopril—coronary artery disease	4.18e-05	0.000429	CcSEcCtD
Lisdexamfetamine—Rash—Timolol—coronary artery disease	4.15e-05	0.000426	CcSEcCtD
Lisdexamfetamine—Dermatitis—Timolol—coronary artery disease	4.15e-05	0.000426	CcSEcCtD
Lisdexamfetamine—Headache—Timolol—coronary artery disease	4.13e-05	0.000423	CcSEcCtD
Lisdexamfetamine—Dizziness—Lisinopril—coronary artery disease	4.04e-05	0.000415	CcSEcCtD
Lisdexamfetamine—Nausea—Ramipril—coronary artery disease	4e-05	0.000411	CcSEcCtD
Lisdexamfetamine—Nausea—Timolol—coronary artery disease	3.91e-05	0.000401	CcSEcCtD
Lisdexamfetamine—Vomiting—Lisinopril—coronary artery disease	3.89e-05	0.000399	CcSEcCtD
Lisdexamfetamine—Rash—Lisinopril—coronary artery disease	3.85e-05	0.000395	CcSEcCtD
Lisdexamfetamine—Dermatitis—Lisinopril—coronary artery disease	3.85e-05	0.000395	CcSEcCtD
Lisdexamfetamine—Headache—Lisinopril—coronary artery disease	3.83e-05	0.000393	CcSEcCtD
Lisdexamfetamine—Nausea—Lisinopril—coronary artery disease	3.63e-05	0.000372	CcSEcCtD
Lisdexamfetamine—SLC18A2—Neuronal System—MAPK1—coronary artery disease	1.59e-05	0.000499	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—P2RY12—coronary artery disease	1.59e-05	0.000499	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PLCB3—coronary artery disease	1.59e-05	0.000499	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	1.58e-05	0.000496	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CASR—coronary artery disease	1.58e-05	0.000494	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.55e-05	0.000485	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AVPR1A—coronary artery disease	1.55e-05	0.000484	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—BDKRB1—coronary artery disease	1.55e-05	0.000484	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GNA12—coronary artery disease	1.55e-05	0.000484	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LRP8—coronary artery disease	1.54e-05	0.000481	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RLN3—coronary artery disease	1.54e-05	0.000481	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DGKZ—coronary artery disease	1.54e-05	0.000481	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	1.53e-05	0.000478	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADM—coronary artery disease	1.5e-05	0.000471	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—UTS2—coronary artery disease	1.49e-05	0.000468	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—PLG—coronary artery disease	1.48e-05	0.000465	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	1.48e-05	0.000464	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDN2—coronary artery disease	1.47e-05	0.000461	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AES—coronary artery disease	1.47e-05	0.000461	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4B—coronary artery disease	1.47e-05	0.000459	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	1.46e-05	0.000459	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—EDN1—coronary artery disease	1.45e-05	0.000455	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PLCB3—coronary artery disease	1.45e-05	0.000453	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—P2RY12—coronary artery disease	1.45e-05	0.000453	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL5—coronary artery disease	1.44e-05	0.000452	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CX3CR1—coronary artery disease	1.43e-05	0.000449	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CASR—coronary artery disease	1.43e-05	0.000449	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HRH2—coronary artery disease	1.42e-05	0.000444	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—BDKRB1—coronary artery disease	1.4e-05	0.00044	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CX3CL1—coronary artery disease	1.4e-05	0.00044	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GNA12—coronary artery disease	1.4e-05	0.00044	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ALB—coronary artery disease	1.38e-05	0.000433	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PPP3R1—coronary artery disease	1.38e-05	0.000432	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.37e-05	0.000429	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADM—coronary artery disease	1.37e-05	0.000428	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCR3—coronary artery disease	1.34e-05	0.00042	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	1.33e-05	0.000418	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4B—coronary artery disease	1.33e-05	0.000417	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—APOB—coronary artery disease	1.31e-05	0.000411	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	1.3e-05	0.000409	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RHOC—coronary artery disease	1.29e-05	0.000403	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ACVR1B—coronary artery disease	1.29e-05	0.000403	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2A—coronary artery disease	1.27e-05	0.000398	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—C3—coronary artery disease	1.27e-05	0.000398	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL2—coronary artery disease	1.26e-05	0.000395	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NEDD4—coronary artery disease	1.25e-05	0.000392	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—F2R—coronary artery disease	1.25e-05	0.00039	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	1.24e-05	0.000388	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MDK—coronary artery disease	1.22e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PF4—coronary artery disease	1.22e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RAMP2—coronary artery disease	1.22e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE3A—coronary artery disease	1.22e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCR3—coronary artery disease	1.22e-05	0.000381	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDNRB—coronary artery disease	1.21e-05	0.000378	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—AGT—coronary artery disease	1.21e-05	0.000378	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.17e-05	0.000367	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RALBP1—coronary artery disease	1.16e-05	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—F2RL1—coronary artery disease	1.16e-05	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPY5R—coronary artery disease	1.16e-05	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL2—coronary artery disease	1.14e-05	0.000359	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL3—coronary artery disease	1.14e-05	0.000359	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDNRA—coronary artery disease	1.14e-05	0.000357	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB1—coronary artery disease	1.13e-05	0.000356	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—F2R—coronary artery disease	1.13e-05	0.000355	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FZD2—coronary artery disease	1.12e-05	0.00035	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—UTS2R—coronary artery disease	1.12e-05	0.00035	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—F2—coronary artery disease	1.11e-05	0.000349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRB—coronary artery disease	1.1e-05	0.000343	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SFRP2—coronary artery disease	1.09e-05	0.000343	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADORA1—coronary artery disease	1.07e-05	0.000337	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADORA3—coronary artery disease	1.07e-05	0.000337	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOA4—coronary artery disease	1.07e-05	0.000337	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—BDKRB2—coronary artery disease	1.07e-05	0.000336	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL12—coronary artery disease	1.07e-05	0.000336	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PLCB1—coronary artery disease	1.05e-05	0.000328	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.04e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PGF—coronary artery disease	1.04e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPBP—coronary artery disease	1.04e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDNRA—coronary artery disease	1.03e-05	0.000324	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	1.03e-05	0.000323	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB1—coronary artery disease	1.03e-05	0.000323	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR7—coronary artery disease	1.03e-05	0.000322	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGA2B—coronary artery disease	1.02e-05	0.00032	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DVL1—coronary artery disease	1.02e-05	0.00032	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	1.02e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—POMC—coronary artery disease	1.02e-05	0.000318	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCL2—coronary artery disease	9.94e-06	0.000311	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OPRD1—coronary artery disease	9.89e-06	0.00031	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GHR—coronary artery disease	9.89e-06	0.00031	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL4—coronary artery disease	9.89e-06	0.00031	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—PIK3CA—coronary artery disease	9.88e-06	0.00031	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—KNG1—coronary artery disease	9.75e-06	0.000305	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL12—coronary artery disease	9.73e-06	0.000305	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—BDKRB2—coronary artery disease	9.73e-06	0.000305	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGTR1—coronary artery disease	9.69e-06	0.000304	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PLCB1—coronary artery disease	9.52e-06	0.000298	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAPK1—coronary artery disease	9.49e-06	0.000297	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TLE4—coronary artery disease	9.49e-06	0.000297	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MEF2A—coronary artery disease	9.49e-06	0.000297	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL10—coronary artery disease	9.47e-06	0.000297	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR7—coronary artery disease	9.32e-06	0.000292	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	9.29e-06	0.000291	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOA2—coronary artery disease	9.24e-06	0.00029	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADRB2—coronary artery disease	9.19e-06	0.000288	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AVPR1A—coronary artery disease	9.13e-06	0.000286	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCE—coronary artery disease	9.08e-06	0.000284	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—KNG1—coronary artery disease	8.85e-06	0.000277	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	8.84e-06	0.000277	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—UTS2—coronary artery disease	8.82e-06	0.000276	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGTR1—coronary artery disease	8.8e-06	0.000276	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NR4A1—coronary artery disease	8.63e-06	0.00027	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL10—coronary artery disease	8.6e-06	0.000269	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLCB3—coronary artery disease	8.54e-06	0.000268	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—P2RY12—coronary artery disease	8.54e-06	0.000268	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HDAC9—coronary artery disease	8.54e-06	0.000268	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CX3CR1—coronary artery disease	8.46e-06	0.000265	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CASR—coronary artery disease	8.46e-06	0.000265	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADRB2—coronary artery disease	8.35e-06	0.000262	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GNA12—coronary artery disease	8.29e-06	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—P4HB—coronary artery disease	8.29e-06	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—BDKRB1—coronary artery disease	8.29e-06	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CX3CL1—coronary artery disease	8.29e-06	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCE—coronary artery disease	8.24e-06	0.000258	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ALB—coronary artery disease	8.23e-06	0.000258	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—EDN1—coronary artery disease	8.21e-06	0.000257	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCL5—coronary artery disease	8.15e-06	0.000255	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPP3R1—coronary artery disease	8.14e-06	0.000255	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADM—coronary artery disease	8.07e-06	0.000253	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CSF2—coronary artery disease	8.03e-06	0.000252	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBB—coronary artery disease	7.86e-06	0.000246	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4B—coronary artery disease	7.86e-06	0.000246	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CXCL8—coronary artery disease	7.86e-06	0.000246	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—MMP3—coronary artery disease	7.84e-06	0.000246	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	7.83e-06	0.000245	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—EDN1—coronary artery disease	7.46e-06	0.000234	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL5—coronary artery disease	7.4e-06	0.000232	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PRKCD—coronary artery disease	7.34e-06	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CSF2—coronary artery disease	7.29e-06	0.000228	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCR3—coronary artery disease	7.19e-06	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—coronary artery disease	7.19e-06	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—C3—coronary artery disease	7.18e-06	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CRK—coronary artery disease	7.1e-06	0.000222	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SH2B3—coronary artery disease	7.01e-06	0.00022	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ATP2A2—coronary artery disease	7.01e-06	0.00022	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VWF—coronary artery disease	7.01e-06	0.00022	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOC3—coronary artery disease	6.96e-06	0.000218	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LDLR—coronary artery disease	6.92e-06	0.000217	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AGT—coronary artery disease	6.82e-06	0.000214	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PPP2CA—coronary artery disease	6.79e-06	0.000213	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL2—coronary artery disease	6.76e-06	0.000212	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL3—coronary artery disease	6.76e-06	0.000212	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—F2R—coronary artery disease	6.68e-06	0.000209	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SDC1—coronary artery disease	6.68e-06	0.000209	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PRKCD—coronary artery disease	6.67e-06	0.000209	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGB—coronary artery disease	6.54e-06	0.000205	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—coronary artery disease	6.53e-06	0.000204	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—C3—coronary artery disease	6.52e-06	0.000204	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRB—coronary artery disease	6.47e-06	0.000203	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—THBS1—coronary artery disease	6.38e-06	0.0002	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PSMB5—coronary artery disease	6.31e-06	0.000198	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PSMA6—coronary artery disease	6.31e-06	0.000198	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—F2—coronary artery disease	6.3e-06	0.000197	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AGT—coronary artery disease	6.19e-06	0.000194	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDNRA—coronary artery disease	6.11e-06	0.000192	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CYBA—coronary artery disease	6.09e-06	0.000191	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB1—coronary artery disease	6.09e-06	0.000191	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DUSP6—coronary artery disease	6.06e-06	0.00019	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLAT—coronary artery disease	5.96e-06	0.000187	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—BDKRB2—coronary artery disease	5.75e-06	0.00018	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL12—coronary artery disease	5.75e-06	0.00018	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—POMC—coronary artery disease	5.74e-06	0.00018	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—F2—coronary artery disease	5.72e-06	0.000179	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6ST—coronary artery disease	5.7e-06	0.000179	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—JUNB—coronary artery disease	5.64e-06	0.000177	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLCB1—coronary artery disease	5.62e-06	0.000176	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR7—coronary artery disease	5.5e-06	0.000172	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGAV—coronary artery disease	5.24e-06	0.000164	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KNG1—coronary artery disease	5.23e-06	0.000164	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—POMC—coronary artery disease	5.21e-06	0.000163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	5.21e-06	0.000163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	5.2e-06	0.000163	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	5.1e-06	0.00016	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	5.08e-06	0.000159	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	5.08e-06	0.000159	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLG—coronary artery disease	5.07e-06	0.000159	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	4.93e-06	0.000155	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	4.87e-06	0.000153	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	4.86e-06	0.000152	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	4.86e-06	0.000152	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—S100B—coronary artery disease	4.84e-06	0.000152	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	4.8e-06	0.00015	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	4.74e-06	0.000149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	4.74e-06	0.000149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	4.63e-06	0.000145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	4.63e-06	0.000145	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOB—coronary artery disease	4.48e-06	0.00014	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	4.44e-06	0.000139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	4.42e-06	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	4.41e-06	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	4.37e-06	0.000137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	4.31e-06	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	4.31e-06	0.000135	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LPL—coronary artery disease	4.28e-06	0.000134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	4.24e-06	0.000133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	4.24e-06	0.000133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	4.13e-06	0.000129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	4.03e-06	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	4.01e-06	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	3.94e-06	0.000123	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	3.85e-06	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—C3—coronary artery disease	3.85e-06	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	3.67e-06	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AGT—coronary artery disease	3.66e-06	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—LEP—coronary artery disease	3.58e-06	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOE—coronary artery disease	3.58e-06	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	3.54e-06	0.000111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KDR—coronary artery disease	3.51e-06	0.00011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	3.49e-06	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	3.42e-06	0.000107	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—F2—coronary artery disease	3.38e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	3.38e-06	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	3.37e-06	0.000105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	3.34e-06	0.000105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	3.23e-06	0.000101	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	3.1e-06	9.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	3.08e-06	9.65e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	3.08e-06	9.65e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	3.01e-06	9.44e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	3e-06	9.41e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	2.96e-06	9.28e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	2.95e-06	9.24e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.82e-06	8.82e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	2.81e-06	8.81e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	2.72e-06	8.53e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	2.68e-06	8.41e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	2.61e-06	8.18e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.56e-06	8.01e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	2.38e-06	7.46e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	2.3e-06	7.21e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	2.28e-06	7.14e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	2.26e-06	7.1e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	2.22e-06	6.95e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	2.15e-06	6.75e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	2.09e-06	6.55e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.93e-06	6.06e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.78e-06	5.56e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.74e-06	5.46e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.51e-06	4.73e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.34e-06	4.19e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.23e-06	3.87e-05	CbGpPWpGaD
